RPG Life Sciences: To continue moving towards Life time high

 

  • RPG Life Sciences: To continue moving towards Life time high
  • For the full fiscal year FY24 too, the company achieved a 29% year-on-year increase in PAT 
  • Saw an expansion of EBITDA margin from 21.0% to 23.3% year-on-year. 
  • Revenue from operations, totaling Rs 582.05 crores, experienced a 14% Y-O-Y growth for FY24.
  • Top priority, Domestic Formulations, the biggest contributor to the Company’s business, recorded robust growth in both value and volume
  • To enter other specialties like Gastro and Derma to emerge as future growth drivers of Domestic Formulations business
  • Structural approach of cost optimization has helped explore newer avenues in operations to achieve cost efficiencies, helping to maintain 5-year uninterrupted Y-o-Y margin expansion trajectory for the past 5 consecutive years

Comments

Popular posts from this blog

Confidence Petroleum Forays into Hydrogen Cylinder Manufacturing

RSI Indicator for finding good value stocks?

Poonawalla Fincorp: I love stocks at 52L